Literature DB >> 2846311

Species-specificity of estradiol regulated growth factors in breast cancer.

A Manni1, B Badger, C Wright, J Glenn, S R Ahmed, L M Demers.   

Abstract

Recent evidence indicates that autocrine/paracrine mechanisms may mediate the mitogenic effect of estradiol (E2) both in human and experimental breast cancer. However, the species-specificity of E2-regulated growth factors with regard to their biologic action has not been evaluated. To test this issue, we examined, in the soft agar clonogenic assay, the colony-stimulating activity in human breast cancers of conditioned media obtained from rat mammary carcinomas exposed to E2 (rat E2-CM). Of 22 primary human breast cancers plated in soft agar in the absence of serum, 18 (82%) successfully grew with a mean colony number of 62.4 +/- 9.8 (S.E.M.) (range 14-193). Rat E2-CM significantly stimulated colony formation in 10/18 (56%) human breast cancers to 155 +/- 11% (S.E.M.) of control. E2 administration (10(-9) M) in these tumors had a virtually identical overall effect (154 +/- 13% of control colony number). In the remaining eight tumors (44%), neither rat E2-CM nor E2 had, in general, a significant colony-stimulating effect. The growth-promoting action of rat E2-CM and E2 was not influenced by the hormone receptor status of the tumor. These results suggest that E2-regulated growth factors may not be species-specific, at least with regard to their colony-stimulating effects in soft agar.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2846311     DOI: 10.1016/0277-5379(88)90227-1

Source DB:  PubMed          Journal:  Eur J Cancer Clin Oncol        ISSN: 0277-5379


  2 in total

Review 1.  Corticostriatal Regulation of Language Functions.

Authors:  David A Copland; Sonia Brownsett; Kartik Iyer; Anthony J Angwin
Journal:  Neuropsychol Rev       Date:  2021-05-12       Impact factor: 7.444

2.  Role of transforming growth factor-alpha-related peptides in the autocrine/paracrine control of experimental breast cancer growth in vitro by estradiol, prolactin, and progesterone.

Authors:  A Manni; C Wright; B Badger; M Bartholomew; M Herlyn; J Mendelsohn; H Masui; L Demers
Journal:  Breast Cancer Res Treat       Date:  1990-02       Impact factor: 4.872

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.